Ten priority drugs approved in ’06

Ten priority drugs were approved in 2006, the FDA says, down five from 2005.

James G. Dickinson

May 1, 2007

4:00 am

Ten priority drugs were approved in 2006, the FDA says, down five from 2005. The median review time remained unchanged at six months, down from 15.8 months in 2005. The number of new drugs filed for approval in 2006 was 29, down from 33 in 2005 and 32 in 2004.

From the May 01, 2007 Issue of MM+M - Medical Marketing and Media

From Our Partners

Prioritizing audience quality and contextual environment in POC marketing

Partner Content

Prioritizing audience quality and contextual environment in POC marketing

Despite the growing popularity of POC marketing via EHR platforms, this channel remains highly fragmented. For omnichannel marketers, that fragmentation can represent challenges in finding scale, transparency, and uniformity in targeting and performance reporting.

Want to better engage patients with complex diagnoses? Embrace digital.

Partner Content

Want to better engage patients with complex diagnoses? Embrace digital.

Patients often struggle to find specialist care, delaying needed treatment. Digital tools can help.

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

Partner Content

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a paradigm shift in the pharmaceutical industry's approach to patient support.

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.